We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2012 by Dost Ongur, Mclean Hospital.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01688765
First Posted: September 20, 2012
Last Update Posted: September 20, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Dost Ongur, Mclean Hospital
  Purpose
The purpose of this study is to investigate the structural, functional and chemical brain abnormalities in patients with first episode psychosis and assess the evolution of these abnormalities during the course of the disease.

Condition
Psychotic Disorders

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis

Resource links provided by NLM:


Further study details as provided by Dost Ongur, Mclean Hospital:

Estimated Enrollment: 200
Study Start Date: October 2012
Groups/Cohorts
First Episode Psychosis Patients
Healthy Controls

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
First episode psychosis patients Healthy controls
Criteria

Inclusion Criteria:

  • Clinical diagnosis of first episode of a psychotic disorder
  • Healthy controls with no psychiatric disorder history

Exclusion Criteria:

  • Significant neurological or medical illness history
  • Ages <18 or >45
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01688765


Locations
United States, Massachusetts
McLean Hospital Not yet recruiting
Belmont, Massachusetts, United States, 02478
Contact: Samira Pingali    617-855-2370    spingali@mclean.harvard.edu   
Sponsors and Collaborators
Mclean Hospital
  More Information

Responsible Party: Dost Ongur, M.D, PhD, Clinical Director, Mclean Hospital
ClinicalTrials.gov Identifier: NCT01688765     History of Changes
Other Study ID Numbers: 2012P001796
First Submitted: September 17, 2012
First Posted: September 20, 2012
Last Update Posted: September 20, 2012
Last Verified: September 2012

Keywords provided by Dost Ongur, Mclean Hospital:
Schizophrenia
Schizoaffective disorder
Bipolar disorder

Additional relevant MeSH terms:
Psychotic Disorders
Mental Disorders
Schizophrenia Spectrum and Other Psychotic Disorders